Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 88 articles:
HTML format
Text format



Single Articles


    March 2017
  1. PAPP KV, Rentz DM, Mormino EC, Schultz AP, et al
    Cued memory decline in biomarker-defined preclinical Alzheimer disease.
    Neurology. 2017 Mar 10. pii: 10.1212/WNL.0000000000003812.
    PubMed     Text format     Abstract available


    February 2017
  2. DAY GS, Lim TS, Hassenstab J, Goate AM, et al
    Differentiating cognitive impairment due to corticobasal degeneration and Alzheimer disease.
    Neurology. 2017 Feb 24. pii: 10.1212/WNL.0000000000003770.
    PubMed     Text format     Abstract available


  3. TOSTO G, Bird TD, Tsuang D, Bennett DA, et al
    Polygenic risk scores in familial Alzheimer disease.
    Neurology. 2017 Feb 17. pii: 10.1212/WNL.0000000000003734.
    PubMed     Text format     Abstract available


  4. IMTIAZ B, Tuppurainen M, Rikkonen T, Kivipelto M, et al
    Postmenopausal hormone therapy and Alzheimer disease: A prospective cohort study.
    Neurology. 2017 Feb 15. pii: 10.1212/WNL.0000000000003696.
    PubMed     Text format     Abstract available


  5. FRANZMEIER N, Duering M, Weiner M, Dichgans M, et al
    Left frontal cortex connectivity underlies cognitive reserve in prodromal Alzheimer disease.
    Neurology. 2017 Feb 10. pii: 10.1212/WNL.0000000000003711.
    PubMed     Text format     Abstract available


  6. KREISL WC, Lawrence R, Page E, Teich AF, et al
    11C-PBR28 PET detects translocator protein in a patient with astrocytoma and Alzheimer disease.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003693.
    PubMed     Text format    


    January 2017
  7. FEDOROVA TD, Seidelin LB, Knudsen K, Schacht AC, et al
    Decreased intestinal acetylcholinesterase in early Parkinson disease: An 11C-donepezil PET study.
    Neurology. 2017 Jan 18. pii: 10.1212/WNL.0000000000003633.
    PubMed     Text format     Abstract available


    December 2016
  8. ENNIS GE, An Y, Resnick SM, Ferrucci L, et al
    Long-term cortisol measures predict Alzheimer disease risk.
    Neurology. 2016 Dec 16. pii: 10.1212/WNL.0000000000003537.
    PubMed     Text format     Abstract available


    November 2016
  9. MOKRY LE, Ross S, Morris JA, Manousaki D, et al
    Genetically decreased vitamin D and risk of Alzheimer disease.
    Neurology. 2016 Nov 16. pii: 10.1212/WNL.0000000000003430.
    PubMed     Text format     Abstract available


  10. HOHMAN TJ, McLaren DG, Mormino EC, Gifford KA, et al
    Asymptomatic Alzheimer disease: Defining resilience.
    Neurology. 2016 Nov 4. pii: 10.1212/WNL.0000000000003397.
    PubMed     Text format     Abstract available


    October 2016
  11. ZHAN X, Stamova B, Jin LW, DeCarli C, et al
    Gram-negative bacterial molecules associate with Alzheimer disease pathology.
    Neurology. 2016 Oct 26. pii: 10.1212/WNL.0000000000003391.
    PubMed     Text format     Abstract available


  12. WESTON PS, Nicholas JM, Lehmann M, Ryan NS, et al
    Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study.
    Neurology. 2016 Oct 12. pii: 10.1212/WNL.0000000000003322.
    PubMed     Text format     Abstract available


  13. MATTIS PJ, Niethammer M, Sako W, Tang CC, et al
    Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases.
    Neurology. 2016 Oct 5. pii: 10.1212/WNL.0000000000003285.
    PubMed     Text format     Abstract available


    September 2016
  14. MATTSSON N, Zetterberg H, Janelidze S, Insel PS, et al
    Plasma tau in Alzheimer disease.
    Neurology. 2016 Sep 30. pii: 10.1212/WNL.0000000000003246.
    PubMed     Text format     Abstract available


    August 2016
  15. ROGALSKI E, Sridhar J, Rader B, Martersteck A, et al
    Aphasic variant of Alzheimer disease: Clinical, anatomic, and genetic features.
    Neurology. 2016 Aug 26. pii: 10.1212/WNL.0000000000003165.
    PubMed     Text format     Abstract available


  16. BURNHAM SC, Rowe CC, Baker D, Bush AI, et al
    Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up.
    Neurology. 2016 Aug 17. pii: 10.1212/WNL.0000000000003094.
    PubMed     Text format     Abstract available


    July 2016
  17. ZAREA A, Charbonnier C, Rovelet-Lecrux A, Nicolas G, et al
    Seizures in dominantly inherited Alzheimer disease.
    Neurology. 2016 Jul 27. pii: 10.1212/WNL.0000000000003048.
    PubMed     Text format     Abstract available


  18. KNOPMAN DS, Jack CR Jr, Wiste HJ, Weigand SD, et al
    Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia.
    Neurology. 2016 Jul 15. pii: 10.1212/WNL.0000000000002979.
    PubMed     Text format     Abstract available


  19. KNICKMEYER RC, Ross ME
    Imaging and rare APOE alleles: Alzheimer disease as a developmental disorder.
    Neurology. 2016 Jul 13. pii: 10.1212/WNL.0000000000002956.
    PubMed     Text format    


  20. MORMINO EC, Sperling RA, Holmes AJ, Buckner RL, et al
    Polygenic risk of Alzheimer disease is associated with early- and late-life processes.
    Neurology. 2016 Jul 6. pii: 10.1212/WNL.0000000000002922.
    PubMed     Text format     Abstract available


  21. JACK CR JR, Bennett DA, Blennow K, Carrillo MC, et al
    A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.
    Neurology. 2016 Jul 1. pii: 10.1212/WNL.0000000000002923.
    PubMed     Text format     Abstract available


  22. FARFEL JM, Yu L, Buchman AS, Schneider JA, et al
    Relation of genomic variants for Alzheimer disease dementia to common neuropathologies.
    Neurology. 2016 Jul 1. pii: 10.1212/WNL.0000000000002909.
    PubMed     Text format     Abstract available


    June 2016
  23. CHO H, Choi JY, Hwang MS, Lee JH, et al
    Tau PET in Alzheimer disease and mild cognitive impairment.
    Neurology. 2016 Jun 29. pii: 10.1212/WNL.0000000000002892.
    PubMed     Text format     Abstract available


  24. COLLOBY SJ, McKeith IG, Burn DJ, Wyper DJ, et al
    Cholinergic and perfusion brain networks in Parkinson disease dementia.
    Neurology. 2016 Jun 15. pii: 10.1212/WNL.0000000000002839.
    PubMed     Text format     Abstract available


    May 2016
  25. VOEVODSKAYA O, Sundgren PC, Strandberg O, Zetterberg H, et al
    Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
    Neurology. 2016;86:1754-61.
    PubMed     Text format     Abstract available


    April 2016
  26. VAN DEN BOSSCHE T, Sleegers K, Cuyvers E, Engelborghs S, et al
    Phenotypic characteristics of Alzheimer patients carrying an ABCA7 mutation.
    Neurology. 2016 Apr 1. pii: 10.1212/WNL.0000000000002628.
    PubMed     Text format     Abstract available


  27. SWERDLOW RH
    Rare ABCA7 variants in Alzheimer disease: Guilt by association.
    Neurology. 2016 Apr 1. pii: 10.1212/WNL.0000000000002630.
    PubMed     Text format    


  28. LE GUENNEC K, Nicolas G, Quenez O, Charbonnier C, et al
    ABCA7 rare variants and Alzheimer disease risk.
    Neurology. 2016 Apr 1. pii: 10.1212/WNL.0000000000002627.
    PubMed     Text format     Abstract available


    March 2016
  29. LIM YY, Laws SM, Villemagne VL, Pietrzak RH, et al
    Abeta-related memory decline in APOE epsilon4 noncarriers: Implications for Alzheimer disease.
    Neurology. 2016 Mar 30. pii: 10.1212/WNL.0000000000002604.
    PubMed     Text format     Abstract available


  30. XIONG C, Jasielec MS, Weng H, Fagan AM, et al
    Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study.
    Neurology. 2016 Mar 23. pii: 10.1212/WNL.0000000000002593.
    PubMed     Text format     Abstract available


  31. GUTIERREZ J, Honig L, Elkind MS, Mohr JP, et al
    Brain arterial aging and its relationship to Alzheimer dementia.
    Neurology. 2016 Mar 16. pii: 10.1212/WNL.0000000000002590.
    PubMed     Text format     Abstract available


  32. WHITE LR, Edland SD, Hemmy LS, Montine KS, et al
    Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies.
    Neurology. 2016;86:1000-8.
    PubMed     Text format     Abstract available


  33. LANDAU SM, Horng A, Fero A, Jagust WJ, et al
    Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI.
    Neurology. 2016 Mar 11. pii: 10.1212/WNL.0000000000002576.
    PubMed     Text format     Abstract available


    February 2016
  34. VEMURI P, Lesnick TG, Przybelski SA, Knopman DS, et al
    Effect of intellectual enrichment on AD biomarker trajectories: Longitudinal imaging study.
    Neurology. 2016 Feb 24. pii: 10.1212/WNL.0000000000002490.
    PubMed     Text format     Abstract available


  35. GROSSMAN-KAHN R
    Reflections: Neurology and The Humanities. Charades with Alzheimer disease.
    Neurology. 2016;86:e73-4.
    PubMed     Text format    


  36. RANASINGHE KG, Rankin KP, Lobach IV, Kramer JH, et al
    Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage.
    Neurology. 2016;86:600-10.
    PubMed     Text format     Abstract available


    January 2016
  37. WELLINGTON H, Paterson RW, Portelius E, Tornqvist U, et al
    Increased CSF neurogranin concentration is specific to Alzheimer disease.
    Neurology. 2016 Jan 29. pii: 10.1212/WNL.0000000000002423.
    PubMed     Text format     Abstract available


  38. BEERI MS, Sonnen J
    Brain BDNF expression as a biomarker for cognitive reserve against Alzheimer disease progression.
    Neurology. 2016 Jan 27. pii: 10.1212/WNL.0000000000002389.
    PubMed     Text format    


  39. DEL CAMPO N, Payoux P, Djilali A, Delrieu J, et al
    Relationship of regional brain beta-amyloid to gait speed.
    Neurology. 2016;86:36-43.
    PubMed     Text format     Abstract available


    December 2015

  40. Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial.
    Neurology. 2015;85:2084.
    PubMed     Text format    


  41. TUFAN AN, Tufan F, Holmes C
    Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial.
    Neurology. 2015;85:2083-4.
    PubMed     Text format    


  42. HOLMES C
    Author Response.
    Neurology. 2015;85:2084.
    PubMed     Text format    


  43. BOYLE PA, Yu L, Nag S, Leurgans S, et al
    Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons.
    Neurology. 2015;85:1930-6.
    PubMed     Text format     Abstract available


    November 2015
  44. HENDERSON VW, Ala T, Sainani KL, Bernstein AL, et al
    Raloxifene for women with Alzheimer disease: A randomized controlled pilot trial.
    Neurology. 2015 Nov 4. pii: 10.1212/WNL.0000000000002171.
    PubMed     Text format     Abstract available


    October 2015
  45. ZWAN MD, Rinne JO, Hasselbalch SG, Nordberg A, et al
    Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study.
    Neurology. 2015 Oct 14. pii: 10.1212/WNL.0000000000002081.
    PubMed     Text format     Abstract available


  46. AHMED RM, Latheef S, Bartley L, Irish M, et al
    Eating behavior in frontotemporal dementia: Peripheral hormones vs hypothalamic pathology.
    Neurology. 2015;85:1310-7.
    PubMed     Text format     Abstract available


    September 2015
  47. MORAN C, Beare R, Phan TG, Bruce DG, et al
    Type 2 diabetes mellitus and biomarkers of neurodegeneration.
    Neurology. 2015;85:1123-30.
    PubMed     Text format     Abstract available


  48. LANDY KM, Salmon DP, Galasko D, Filoteo JV, et al
    Motion discrimination in dementia with Lewy bodies and Alzheimer disease.
    Neurology. 2015 Sep 23. pii: 10.1212/WNL.0000000000002028.
    PubMed     Text format     Abstract available


  49. TURNER RS, Thomas RG, Craft S, van Dyck CH, et al
    A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease.
    Neurology. 2015 Sep 11. pii: 10.1212/WNL.0000000000002035.
    PubMed     Text format     Abstract available


  50. PALMQVIST S, Zetterberg H, Mattsson N, Johansson P, et al
    Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease.
    Neurology. 2015 Sep 9. pii: 10.1212/WNL.0000000000001991.
    PubMed     Text format     Abstract available


    August 2015
  51. KNOPMAN DS
    Is dominantly inherited Alzheimer disease a clone of sporadic Alzheimer disease?
    Neurology. 2015 Aug 5. pii: 10.1212/WNL.0000000000001897.
    PubMed     Text format    


  52. WANG F, Gordon BA, Ryman DC, Ma S, et al
    Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease.
    Neurology. 2015 Aug 5. pii: 10.1212/WNL.0000000000001903.
    PubMed     Text format     Abstract available


    July 2015
  53. CHILDRESS MD, Chen DT
    Art and Alzheimer dementia: A museum experience for patients may benefit medical students.
    Neurology. 2015 Jul 29. pii: 10.1212/WNL.0000000000001874.
    PubMed     Text format    


  54. FICHERA M, Bernasconi MP, Martinelli V, Comi G, et al
    Drawing in Alzheimer-type dementia.
    Neurology. 2015;85:386-7.
    PubMed     Text format    


  55. YONG KX, Rajdev K, Shakespeare TJ, Leff AP, et al
    Facilitating text reading in posterior cortical atrophy.
    Neurology. 2015;85:339-48.
    PubMed     Text format     Abstract available


  56. TIFRATENE K, Robert P, Metelkina A, Pradier C, et al
    Progression of mild cognitive impairment to dementia due to AD in clinical settings.
    Neurology. 2015;85:331-8.
    PubMed     Text format     Abstract available


  57. BREITNER JC
    Yet another "disconnect" between amyloid and Alzheimer disease?
    Neurology. 2015 Jul 24. pii: 10.1212/WNL.0000000000001871.
    PubMed     Text format    


  58. LIU E, Schmidt ME, Margolin R, Sperling R, et al
    Amyloid-beta 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials.
    Neurology. 2015 Jul 24. pii: 10.1212/WNL.0000000000001877.
    PubMed     Text format     Abstract available


  59. CASELLI RJ, Coon EA, Johansson L
    Midlife personality and risk of Alzheimer disease and distress: A 38-year follow-up.
    Neurology. 2015;85:298-9.
    PubMed     Text format    


  60. ALCOLEA D, Martinez-Lage P, Sanchez-Juan P, Olazaran J, et al
    Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease.
    Neurology. 2015 Jul 15. pii: 10.1212/WNL.0000000000001859.
    PubMed     Text format     Abstract available


  61. BARNES LL, Leurgans S, Aggarwal NT, Shah RC, et al
    Mixed pathology is more likely in black than white decedents with Alzheimer dementia.
    Neurology. 2015 Jul 15. pii: 10.1212/WNL.0000000000001834.
    PubMed     Text format     Abstract available


  62. TOLEDO JB, Bjerke M, Chen K, Rozycki M, et al
    Memory, executive, and multidomain subtle cognitive impairment: clinical and biomarker findings.
    Neurology. 2015;85:144-53.
    PubMed     Text format     Abstract available


  63. AMARIGLIO RE, Mormino EC, Pietras AC, Marshall GA, et al
    Subjective cognitive concerns, amyloid-beta, and neurodegeneration in clinically normal elderly.
    Neurology. 2015;85:56-62.
    PubMed     Text format     Abstract available


    June 2015
  64. RAJAN KB, Wilson RS, Weuve J, Barnes LL, et al
    Cognitive impairment 18 years before clinical diagnosis of Alzheimer disease dementia.
    Neurology. 2015 Jun 24. pii: 10.1212/WNL.0000000000001774.
    PubMed     Text format     Abstract available


  65. GOETZL EJ, Boxer A, Schwartz JB, Abner EL, et al
    Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease.
    Neurology. 2015 Jun 10. pii: 10.1212/WNL.0000000000001702.
    PubMed     Text format     Abstract available


  66. GIDICSIN CM, Maye JE, Locascio JJ, Pepin LC, et al
    Cognitive activity relates to cognitive performance but not to Alzheimer disease biomarkers.
    Neurology. 2015 Jun 10. pii: 10.1212/WNL.0000000000001704.
    PubMed     Text format     Abstract available


    May 2015
  67. MASSIMO L, Zee J, Xie SX, McMillan CT, et al
    Occupational attainment influences survival in autopsy-confirmed frontotemporal degeneration.
    Neurology. 2015;84:2070-5.
    PubMed     Text format     Abstract available


  68. OSORIO RS, Gumb T, Pirraglia E, Varga AW, et al
    Sleep-disordered breathing advances cognitive decline in the elderly.
    Neurology. 2015;84:1964-71.
    PubMed     Text format     Abstract available


  69. CONIDI ME, Bernardi L, Puccio G, Smirne N, et al
    Homozygous carriers of APP A713T mutation in an autosomal dominant Alzheimer disease family.
    Neurology. 2015 May 6. pii: 10.1212/WNL.0000000000001648.
    PubMed     Text format     Abstract available


  70. BUTCHART J, Brook L, Hopkins V, Teeling J, et al
    Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial.
    Neurology. 2015 May 1. pii: 10.1212/WNL.0000000000001617.
    PubMed     Text format     Abstract available


  71. GROWDON ME, Schultz AP, Dagley AS, Amariglio RE, et al
    Odor identification and Alzheimer disease biomarkers in clinically normal elderly.
    Neurology. 2015 May 1. pii: 10.1212/WNL.0000000000001614.
    PubMed     Text format     Abstract available


    April 2015
  72. FOURNIER CN, Gearing M, Upadhyayula SR, Klein M, et al
    Head injury does not alter disease progression or neuropathologic outcomes in ALS.
    Neurology. 2015;84:1788-95.
    PubMed     Text format     Abstract available


  73. TAHMASIAN M, Pasquini L, Scherr M, Meng C, et al
    The lower hippocampus global connectivity, the higher its local metabolism in Alzheimer disease.
    Neurology. 2015 Apr 15. pii: 10.1212/WNL.0000000000001575.
    PubMed     Text format     Abstract available


  74. KIM SY, Karlawish J, Berkman BE
    Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials.
    Neurology. 2015;84:1488-94.
    PubMed     Text format     Abstract available


    March 2015
  75. WOLFSGRUBER S, Jessen F, Koppara A, Kleineidam L, et al
    Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI.
    Neurology. 2015;84:1261-8.
    PubMed     Text format     Abstract available


  76. JENSEN-DAHM C, Werner MU, Jensen TS, Ballegaard M, et al
    Discrepancy between stimulus response and tolerance of pain in Alzheimer disease.
    Neurology. 2015 Mar 18. pii: 10.1212/WNL.0000000000001465.
    PubMed     Text format     Abstract available


    February 2015
  77. WANG L, Benzinger TL, Hassenstab J, Blazey T, et al
    Spatially distinct atrophy is linked to beta-amyloid and tau in preclinical Alzheimer disease.
    Neurology. 2015 Feb 25. pii: 10.1212/WNL.0000000000001401.
    PubMed     Text format     Abstract available


  78. SCHNEIDER LS, Kennedy RE, Wang G, Cutter GR, et al
    Differences in Alzheimer disease clinical trial outcomes based on age of the participants.
    Neurology. 2015 Feb 13. pii: 10.1212/WNL.0000000000001376.
    PubMed     Text format     Abstract available


  79. BRASHEAR HR
    Age effects on clinical trial results in Alzheimer dementia.
    Neurology. 2015 Feb 13. pii: 10.1212/WNL.0000000000001381.
    PubMed     Text format    


    January 2015
  80. APOSTOLOVA LG, Hwang KS, Avila D, Elashoff D, et al
    Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures.
    Neurology. 2015 Jan 21. pii: 10.1212/WNL.0000000000001231.
    PubMed     Text format     Abstract available


  81. MASTERS MC, Morris JC, Roe CM
    "Noncognitive" symptoms of early Alzheimer disease: A longitudinal analysis.
    Neurology. 2015 Jan 14. pii: 10.1212/WNL.0000000000001238.
    PubMed     Text format     Abstract available



  82. Midlife personality and risk of Alzheimer disease and distress: A 38-year follow-up.
    Neurology. 2015;84:215.
    PubMed     Text format    


    December 2014
  83. DEVANAND DP, Lee S, Manly J, Andrews H, et al
    Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community.
    Neurology. 2014 Dec 3. pii: 10.1212/WNL.0000000000001132.
    PubMed     Text format     Abstract available


  84. KOSIK KS, Munoz C, Lopez L, Arcila ML, et al
    Homozygosity of the autosomal dominant Alzheimer disease presenilin 1 E280A mutation.
    Neurology. 2014 Dec 3. pii: 10.1212/WNL.0000000000001130.
    PubMed     Text format    


    November 2014
  85. AHMED RM, MacMillan M, Bartley L, Halliday GM, et al
    Systemic metabolism in frontotemporal dementia.
    Neurology. 2014;83:1812-8.
    PubMed     Text format     Abstract available


  86. OKONKWO OC, Schultz SA, Oh JM, Larson J, et al
    Physical activity attenuates age-related biomarker alterations in preclinical AD.
    Neurology. 2014;83:1753-60.
    PubMed     Text format     Abstract available


    September 2014
  87. JAMES B, Leurgans S, Bennett D
    Author response.
    Neurology. 2014;83:1302.
    PubMed     Text format    


  88. DICKENS AM, Larkin JR, Griffin JL, Cavey A, et al
    A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis.
    Neurology. 2014 Sep 24. pii: 10.1212/WNL.0000000000000905.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: